Hong Kong vs mainland China — which is the right gateway for Indian investors

Ask an Indian investor "how do I buy China?" and the honest answer is a question back: which China, and through which door? There isn't one Chinese market — there's a layered system of listings, and the route you pick determines your tax bill, your structural risk, your currency exposure, and how hard the whole thing is to operate. Get the gateway choice right and China becomes one of the cleaner foreign markets to own. Get it wrong and you've signed up for renminbi capital controls or a fragile contractual wrapper you didn't need.

There are three practical doors: Hong Kong listings, mainland A-shares via Stock Connect, and US-listed Chinese ADRs. This guide compares them head to head for an Indian resident — and the short version, which we'll then justify carefully, is that Hong Kong is usually the right answer. It has no capital-gains tax, no dividend withholding, no VIE wrapper for most names, no US delisting overhang, and no renminbi capital controls. The other two doors exist for specific reasons; Hong Kong is the default.

The three doors at a glance

	Hong Kong (HKEX)	Mainland A-shares (Stock Connect)	US ADRs
Currency	HKD (pegged to USD)	CNY / offshore CNH	USD
Capital-gains tax at source	0%	0% (provisional, through 2027)	0% (US, for non-residents)
Dividend withholding	0%	10%	~10% (Chinese, via depositary)
Structural risk	Low (direct equity)	Low (direct equity)	High (VIE wrapper)
Delisting / political risk	Lower	Onshore-specific	High (HFCAA)
Account needed	HK-capable broker	HK broker with Stock Connect	US brokerage
Capital controls	None	RMB outflow controls	None
US estate-tax exposure	None	None	Possible ($60k trap)
Best for	Most China exposure	Onshore-only champions	Convenience if you already have US account

Read that table and the pattern is obvious: Hong Kong wins or ties on almost every axis that matters, and is the only one of the three with no notable downside in its column. Let's unpack why.

Door 1 — Hong Kong listings (the default)

Hong Kong is the global gateway to Chinese equities, and for an Indian investor it's the most open and tax-friendly major market in Asia. The HKEX main board holds roughly $6 trillion in market cap (early 2026) and lists the biggest names in the Chinese economy — Tencent, Alibaba (9988.HK), Meituan, BYD, JD.com (9618.HK), and hundreds more, including all the H-shares (mainland companies dual-listed in HK) and the secondary listings of nearly every large Chinese ADR.

Why Hong Kong is the smart default

• No capital-gains tax. Hong Kong levies zero CGT on residents and non-residents alike. When you sell a Hong Kong-listed Chinese stock at a profit, Hong Kong takes nothing.
• No dividend withholding. Hong Kong imposes no withholding tax on dividends. Compare this to the mainland's 10% — a Hong Kong-listed name pays your dividend in full, gross.
• Direct equity, no VIE wrapper for most names. When you buy an H-share or a Hong Kong-primary listing, you generally own real equity in the company, not a Cayman shell with contracts — sidestepping the central VIE-structure risk that haunts US ADRs. (Some Hong Kong-listed internet names do still use a VIE; check the specific company, but the structural exposure is broadly lower and the legal anchoring better than a pure US ADR.)
• No US delisting overhang. A Hong Kong listing isn't subject to the HFCAA. In fact, the HK secondary listings exist precisely as a safe harbour against US delisting.
• No renminbi capital controls. The Hong Kong dollar is freely convertible and pegged to the USD; you're not navigating RMB outflow restrictions.
• The most open access in Asia. Passport plus address proof, no residency required. Brokers like Interactive Brokers, Futu/Tiger, and HSBC HK all serve Indian residents.

The one catch — full Indian tax, no credit to offset

Hong Kong's "zero tax at source" is a double-edged sword. Because Hong Kong withholds nothing, there's no foreign tax credit to claim — your gains and dividends are taxed in India at your full applicable rate with nothing to offset. That's not a disadvantage versus the alternatives (you'd pay Indian tax anyway); it just means the entire tax bill lands in India. Plan for it: foreign dividends taxed at your slab, gains taxed by holding period, walked through in how US stocks are taxed in India and modelled in the capital-gains calculator. And of course, Schedule FA disclosure applies to every Hong Kong holding — use the Schedule FA helper.

For most Indian investors wanting China exposure, this is where you start and usually where you stop. Hong Kong gives you the big names, clean structure, zero source-country tax, and the easiest access. The dedicated Hong Kong market — its brokers, its index ETFs, its tax treatment — has its own Hong Kong market hub.

Door 2 — Mainland A-shares via Stock Connect

The mainland is the real China in market terms — the deepest, most representative slice, with thousands of onshore-only companies. You reach it via Northbound Stock Connect through a Hong Kong broker, the full mechanics of which are in how to buy A-shares from India via Stock Connect.

When the mainland is worth it

• Onshore-only champions. Many domestic leaders — major baijiu (liquor) names, certain banks, industrial and consumer-staples giants — list only as A-shares with no Hong Kong or US line. Stock Connect is the only retail route to them.
• A different sector mix. The onshore market is far less tech-concentrated than the Hong Kong listings. If you want "real-economy China" rather than "China internet," A-shares deliver it.
• Currently clean capital-gains tax. The provisional foreign-investor CGT exemption (through 2027 as of early 2026) means no Chinese tax on A-share gains via Stock Connect.

The mainland's real drawbacks

• 10% dividend withholding versus Hong Kong's 0% — though the India-China DTAA makes the 10% fully creditable via Form 67, so it's recoverable, just with paperwork.
• Renminbi capital controls. The mainland operates real FX controls; while Stock Connect insulates you from most of this operationally, it's a structural overhang the Hong Kong dollar doesn't have.
• Trading quirks — no Northbound day-trading, restricted short-selling, daily 10%/20% price limits, and an eligibility list that excludes many smaller names. Detailed in the A-shares guide.
• The CGT exemption is provisional, not a permanent treaty right.

The honest verdict: the mainland is a deliberate choice for specific exposure, not a default. If you can't get the company you want any other way, Stock Connect is the route. If the name has a Hong Kong listing, Hong Kong is simpler and (on dividends) cleaner.

Door 3 — US-listed Chinese ADRs

The third door is the one that looks easiest — buy Alibaba (BABA), JD (JD), PDD, or Baidu (BIDU) in dollars through the US brokerage you already use. No HK account, no Stock Connect.

Why it's the weakest default

• The VIE wrapper. A typical Chinese ADR is a receipt over a Cayman shell holding contracts with the real Chinese company — not equity in the company itself. This is the central structural risk, explained fully in Chinese ADRs and VIE-structure risk.
• US delisting / HFCAA risk. Reignited in 2025, the threat of Chinese companies being forced off US exchanges is a live, market-moving political risk as of early 2026.
• Possible US estate-tax exposure. US-listed certificates can fall inside the US non-resident estate-tax net — the $60,000 exemption trap that catches Indians holding US-situs assets. Buying the Hong Kong line generally avoids this entirely.
• Murkier dividend mechanics — Chinese withholding still applies via the depositary, but the path is less clean than a direct holding.

When an ADR still makes sense

• You already have a US account and nothing else, and want a small, convenient China satellite. For a token position, the friction of opening an HK-capable broker may not be worth it.
• The name has no Hong Kong listing — PDD is the notable large example as of early 2026. If you specifically want PDD, the ADR may be the practical route, accepting the higher delisting exposure.

For almost every dual-listed name, though, buy the Hong Kong line instead of the ADR. Same business, no VIE-equivalent US wrapper risk, no US delisting overhang, no US estate-tax exposure, no source-country tax. The ADR's only edge is account convenience — a thin reason given what you're taking on.

The decision tree

Putting it together, here's how to actually choose:

1. Is the company I want available in Hong Kong (H-share, primary, or secondary listing)?
   • Yes → Buy the Hong Kong line. Clean structure, zero source tax, easiest access. This covers the large majority of cases.
2. Is it an onshore-only A-share (no HK or US listing)?
   • Yes → Use mainland A-shares via Stock Connect, accepting 10% dividend WHT (creditable) and the trading quirks.
3. Is it US-only (e.g., PDD as of early 2026), or do I have only a US account and want a token position?
   • Yes → Use the US ADR, eyes open to VIE and delisting risk and possible US estate-tax exposure.

In plain terms: Hong Kong first, mainland for onshore-only names, ADR only when there's no better option.

Currency and capital-control risk, compared

Tax and structure get the headlines, but currency exposure quietly shapes returns over a holding period — and the three doors differ here too.

• Hong Kong dollar (HKD) is pegged to the US dollar within a tight band that the Hong Kong Monetary Authority has defended for four decades. For an Indian investor this means your HK holdings effectively carry USD currency exposure, not a free-floating Asian currency. Your real currency bet is USD/INR — the same exposure you'd have on a US portfolio. There are no capital controls on moving money in or out.
• Renminbi (CNY/CNH) is a managed currency under capital controls. The onshore rate (CNY) and offshore rate (CNH) can diverge, and Beijing actively guides the level. Stock Connect insulates you from most of the operational friction — you don't personally wrangle RMB outflow approvals — but you're holding an asset denominated in a currency the state manages, which is a structural difference from the freely-convertible HKD.
• US ADRs trade in USD, so like Hong Kong your currency bet is USD/INR. No capital-control issue on the currency itself; the risks there are structural and political, not monetary.

The practical upshot: Hong Kong and ADRs give you clean USD-linked exposure, while the mainland adds a managed-currency layer. For a long-term holder, that's another quiet point in Hong Kong's favour. Currency risk in foreign portfolios generally is worth understanding before you size any of these — the rupee's long-run path against the dollar matters as much as the stocks.

What about Indian feeder funds — the fourth, indirect door?

There's a route that sidesteps all three foreign doors: an Indian-domiciled feeder fund that itself holds China exposure. A handful of Greater-China and Asia-focused fund-of-funds (the Edelweiss Greater China Equity Off-shore FoF being the best-known) give Indian investors China exposure without opening any offshore broker account, without using LRS headroom, and without personal Schedule FA disclosure (you own units of an Indian fund, not the foreign asset directly).

The trade-offs:

• Pros: no LRS/TCS, no foreign broker, no Schedule FA on the underlying, rupee-denominated, simple to buy through any Indian platform.
• Cons: higher expense ratios, less control (you can't pick individual names), and — critically — these FoFs are subject to SEBI/RBI overseas-investment limits that have repeatedly halted fresh inflows. When the industry-wide cap is hit, the fund stops accepting new money, sometimes for extended periods.

For an investor who wants broad, hands-off China exposure and values simplicity over control, the feeder route is a legitimate fourth option — and for many it's the most sensible one. It just isn't a direct gateway, so it sits outside the three-door framework above. The China hub notes the current feeder landscape.

What's identical across all three doors

Whichever gateway you choose, the Indian-side plumbing is the same and non-negotiable:

• You fund it under the LRS — $250,000 per financial year, with 20% TCS above Rs 10 lakh (creditable against your tax, but a cash-flow drag). Model it with the LRS / TCS calculator.
• You pay Indian tax on worldwide income — gains by holding period, dividends at slab. Hong Kong dividends have no foreign credit (none was withheld); mainland and ADR dividends carry a 10% Chinese credit claimed via Form 67 (renumbered Form 44 under the Income Tax Act 2025, effective for tax year 2026-27 returns — Form 67 still applies for returns filed in 2026 covering FY 2025-26; verify current) and the Form 67 / FTC calculator.
• You disclose every holding in Schedule FA — mandatory regardless of route or whether you made a gain. The Schedule FA helper handles the valuation math.

The gateway changes your source-country friction. It never changes your home-country obligations.

The bottom line

For the Indian investor, China is best understood as one economy with three access doors of very different quality. Hong Kong is the right default — open, zero source tax, structurally clean, no delisting overhang — and it should be your first stop for any China name that lists there, which is most of them. Mainland A-shares via Stock Connect are the specialist tool for onshore-only champions, worth the extra mechanics only when you genuinely want exposure you can't get elsewhere. US ADRs are the convenient-looking door you should usually walk past in favour of the Hong Kong line, reserving them for US-only names or token positions where you accept the VIE and delisting risk.

Decide the door first, then the stock. To go deeper on each route, read how to buy A-shares via Stock Connect, Chinese ADRs and VIE-structure risk, and China dividend tax and DTAA Form 67. The full overview lives on the China hub and the Hong Kong hub, with the wider universe on the markets page.

---

This is general information, not investment or tax advice. Listing structures, the mainland capital-gains exemption (provisional, through 2027 as understood in early 2026), US delisting policy, and treaty treatment can all change. Verify the current position for each specific holding and consult a qualified cross-border advisor before acting.